Fundraising Fox
Cofactor Genomics
YC S15St. Louis, US · Founded 2015 · Delaware corporation · 13 employees · 18 known investors
Find your way into Cofactor Genomics
Sign up to see every warm intro you have to Cofactor Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cofactor Genomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cofactor Genomics develops predictive diagnostics for cancer immunotherapy using RNA-expression models to characterize tumor microenvironments and predict patient response. The company serves oncology and precision medicine markets by enabling more accurate patient-to-therapy matching.
Founders & leadership· Y Combinator alumni (S15)
Cofactor Genomics was founded in 2015 by Dave Messina, Jarret Glasscock, Jarret Glassock, and Jon Armstrong.
Board
Investors · 18
How we know: Y Combinator's founder network · Not right? Tell us
How we know: a partner's Signal profile · funding news · press coverage · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us
How we know: Fifty Years's portfolio page · the VCSheet dataset · Y Combinator's founder network · Not right? Tell us
How we know: iSelect Fund's portfolio page · Y Combinator's founder network · Not right? Tell us
How we know: Jude Gomila's portfolio page · Not right? Tell us
How we know: Menlo Ventures's portfolio page · board seat on SEC Form D · funding news · press coverage · the VCSheet dataset · Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: the Y Combinator directory · press coverage · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: the VCSheet dataset · Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$18.8M disclosed across 3 rounds · 2017–2023
▶$1.2MraisedAug 2023 · 2 investors · BiotechnologyRule 506(b)
- William HagstromDirector
- David MessinaExecutive Officer
- John KuelperExecutive Officer, Director
- Jarret GlasscockExecutive Officer, Director
- Mark SiegelDirector
- Offering amount
- $2M
- Amount sold
- $1.2M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.9MraisedDec 2021 · 9 investors · BiotechnologyRule 506(b)
- Jarret GlasscockExecutive Officer, Director
- David MessinaDirector
- John KuelperExecutive Officer, Director
- William HagstromDirector
- Armen VidianDirector
- Mark SiegelDirector
- Jon ArmstrongDirector
- Offering amount
- $7.1M
- Amount sold
- $6.9M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.7MraisedJun 2017 · 23 investors · BiotechnologyRule 506(b)
- Jarret GlassockExecutive Officer, Director
- Matthew A. OckoDirector
- Jon ArmstrongDirector
- Mark SiegelDirector
- Offering amount
- $15.1M
- Amount sold
- $10.7M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
4 people who came through Cofactor Genomics went on to found or lead other companies.
Related companies · 9
Companies working in the same space as Cofactor Genomics.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $161.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Legal entities · 2
corporate structureIn the news
Frequently asked questions
- What does Cofactor Genomics do?
- Cofactor Genomics develops predictive diagnostics for cancer immunotherapy using RNA-expression models to characterize tumor microenvironments and predict patient response. The company serves oncology and precision medicine markets by enabling more accurate patient-to-therapy matching.
- Who founded Cofactor Genomics?
- Cofactor Genomics was founded by Dave Messina, Jarret Glasscock, Jarret Glassock, Jon Armstrong in 2015.
- Who are Cofactor Genomics's investors?
- Cofactor Genomics's investors include Argonautic Ventures, Ascension Ventures, DCVC (Data Collective), Fifty Years, iSelect Fund, Jude Gomila, Menlo Ventures, Mission and Market and 10 more.
- How much funding has Cofactor Genomics raised?
- Cofactor Genomics has disclosed $18.8M raised across 3 rounds.
- Where is Cofactor Genomics headquartered?
- Cofactor Genomics is headquartered in St. Louis, US.